Insider Transactions in Q1 2021 at Altimmune, Inc. (ALT)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2021
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,998
-0.64%
|
$25,974
$13.55 P/Share
|
|
Mar 01
2021
|
Philip Hodges Director |
SELL
Open market or private sale
|
Direct |
6,000
-40.73%
|
$96,000
$16.08 P/Share
|
|
Feb 28
2021
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,998
-0.64%
|
$29,970
$15.94 P/Share
|
|
Feb 25
2021
|
Venrock Healthcare Capital Partners Iii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,000,000
-22.22%
|
-
|
|
Jan 31
2021
|
Vipin K Garg President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,055
+0.34%
|
$12,660
$12.14 P/Share
|
|
Jan 31
2021
|
William Michael Brown Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
937
+5.25%
|
$11,244
$12.14 P/Share
|
|
Jan 31
2021
|
M Scot Roberts Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
467
+4.52%
|
$5,604
$12.14 P/Share
|
|
Jan 31
2021
|
Matthew Scott Harris Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
968
+16.12%
|
$11,616
$12.14 P/Share
|
|
Jan 30
2021
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,353
-0.75%
|
$32,942
$14.28 P/Share
|